Tags

Type your tag names separated by a space and hit enter

Erectile dysfunction, discrepancy between high prevalence and low utilization of treatment options: results from the 'Cottbus Survey' with 10 000 men.
BJU Int. 2007 Nov; 100(5):1110-5.BI

Abstract

OBJECTIVE

To investigate the age-stratified prevalence of erectile dysfunction (ED) and its comorbidities, and to assess the population's knowledge, utilization, and general attitude towards the treatment for ED.

SUBJECTS AND METHODS

In all, 10 000 men received a 35-item questionnaire including the International Index of Erectile Function (IIEF) and sociodemographic questions regarding life style, comorbidities, quality of sexual life and knowledge or experience of ED therapy. In all, 3124 responses were included (31.2%), 2499 men lived in well established partnerships and were assessed as the basic study group.

RESULTS

In the entire population the prevalence rate of ED was 40.1%. However, although known, medical treatment for ED is used only by a minority of affected men. The prevalence of ED was independently associated with age, peripheral arterial occlusive disease, hypertension, ischaemic heart disease, diabetes mellitus, and liver diseases. Correlations between sexual quality of life (QoL) and ED were statistically significant (P < 0.01) and moderate to strong (absolute values: Spearman's rho 0.35-0.76). Although 96% of the study population knew at least one phosphodiesterase type 5 (PDE5) inhibitor by name, only 53% considered taking the medication and only 9% of the men with ED had had experience with available PDE5 inhibitors.

CONCLUSIONS

The sexual QoL was significantly reduced by ED. Despite high levels of awareness and general acceptance of oral medication for ED, experience with PDE5 inhibitors was low. Further investigation is required to evaluate the general impact of ED on sexual QoL and the need or wish for treatment.

Authors+Show Affiliations

Department of Urology, Carl-Thiem Hospital, Cottbus, Germany. M.May@ctk.deNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17922788

Citation

May, Matthias, et al. "Erectile Dysfunction, Discrepancy Between High Prevalence and Low Utilization of Treatment Options: Results From the 'Cottbus Survey' With 10 000 Men." BJU International, vol. 100, no. 5, 2007, pp. 1110-5.
May M, Gralla O, Knoll N, et al. Erectile dysfunction, discrepancy between high prevalence and low utilization of treatment options: results from the 'Cottbus Survey' with 10 000 men. BJU Int. 2007;100(5):1110-5.
May, M., Gralla, O., Knoll, N., Fenske, S., Spivak, I., Rönnebeck, C., Hoffmann, M., Lenk, S., & Hoschke, B. (2007). Erectile dysfunction, discrepancy between high prevalence and low utilization of treatment options: results from the 'Cottbus Survey' with 10 000 men. BJU International, 100(5), 1110-5.
May M, et al. Erectile Dysfunction, Discrepancy Between High Prevalence and Low Utilization of Treatment Options: Results From the 'Cottbus Survey' With 10 000 Men. BJU Int. 2007;100(5):1110-5. PubMed PMID: 17922788.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Erectile dysfunction, discrepancy between high prevalence and low utilization of treatment options: results from the 'Cottbus Survey' with 10 000 men. AU - May,Matthias, AU - Gralla,Oliver, AU - Knoll,Nina, AU - Fenske,Stephan, AU - Spivak,Inna, AU - Rönnebeck,Claudia, AU - Hoffmann,Marga, AU - Lenk,Severin, AU - Hoschke,Bernd, PY - 2007/10/10/pubmed PY - 2007/12/6/medline PY - 2007/10/10/entrez SP - 1110 EP - 5 JF - BJU international JO - BJU Int VL - 100 IS - 5 N2 - OBJECTIVE: To investigate the age-stratified prevalence of erectile dysfunction (ED) and its comorbidities, and to assess the population's knowledge, utilization, and general attitude towards the treatment for ED. SUBJECTS AND METHODS: In all, 10 000 men received a 35-item questionnaire including the International Index of Erectile Function (IIEF) and sociodemographic questions regarding life style, comorbidities, quality of sexual life and knowledge or experience of ED therapy. In all, 3124 responses were included (31.2%), 2499 men lived in well established partnerships and were assessed as the basic study group. RESULTS: In the entire population the prevalence rate of ED was 40.1%. However, although known, medical treatment for ED is used only by a minority of affected men. The prevalence of ED was independently associated with age, peripheral arterial occlusive disease, hypertension, ischaemic heart disease, diabetes mellitus, and liver diseases. Correlations between sexual quality of life (QoL) and ED were statistically significant (P < 0.01) and moderate to strong (absolute values: Spearman's rho 0.35-0.76). Although 96% of the study population knew at least one phosphodiesterase type 5 (PDE5) inhibitor by name, only 53% considered taking the medication and only 9% of the men with ED had had experience with available PDE5 inhibitors. CONCLUSIONS: The sexual QoL was significantly reduced by ED. Despite high levels of awareness and general acceptance of oral medication for ED, experience with PDE5 inhibitors was low. Further investigation is required to evaluate the general impact of ED on sexual QoL and the need or wish for treatment. SN - 1464-4096 UR - https://www.unboundmedicine.com/medline/citation/17922788/Erectile_dysfunction_discrepancy_between_high_prevalence_and_low_utilization_of_treatment_options:_results_from_the_'Cottbus_Survey'_with_10_000_men_ L2 - https://doi.org/10.1111/j.1464-410X.2007.07101.x DB - PRIME DP - Unbound Medicine ER -